Bioreactors Market: Information by Product Type, Cell (Mammalian Cells), Molecule (Monoclonal Antibodies), Reactor Volume, End-User (R&D Organization), and Region — Forecast till 2029

Dec 16, 2020   Bioreactors are specially designed containers that are used to grow organisms under user-controlled environments. Bioreactors provide support in the growth of cells (mammalian, bacterial, yeast) with an active environment and features that help in controlling, regulating, and monitoring the culture environment. The bioreactors market was valued at USD 4200 million in 2019 and is expected to grow with a CAGR of 16.5% during the forecast period. The COVID-19 Outbreak to Surge the Need for Rapi...
Request Free Sample Report

Report Description

Bioreactors are specially designed containers that are used to grow organisms under user-controlled environments. Bioreactors provide support in the growth of cells (mammalian, bacterial, yeast) with an active environment and features that help in controlling, regulating, and monitoring the culture environment.

The bioreactors market was valued at USD 4200 million in 2019 and is expected to grow with a CAGR of 16.5% during the forecast period.

Bioreactors-Market

The COVID-19 Outbreak to Surge the Need for Rapid globally Vaccine Development

The demand for bioreactors in the global scenario has escalated significantly, owing to the chaos caused by the pandemic and the ever-growing demand for the development of vaccines and therapeutics. The pandemic has caused havoc and pressurized even the medical infrastructures into crisis. For instance, according to the World Health Organization (WHO), as of November 1, 2020, 45.9 million cases of COVID patients have been confirmed, with the death toll standing at 1.1 million globally.

Umpteen market players are collaborating for the development of effective vaccines to control the rising prevalence of the disease. Thus, demand from the bioreactors market has seen an upsurge in order to cater to the increasing need for fermentation and cell culture and support vaccine development. Further, government authorities and organizations in various regions are also taking up numerous initiatives and indulging in collaborations with key market players for proper management of vaccine development.

Bioreactors-Market-Growth

Rising Incidence of Chronic Disorders to Promote the Use of Bioreactors 

The world has been burdened with the growing incidence of chronic diseases that are affecting millions of people. As per the National Cancer Institute, in 2020, approximately 1.8 million cancer cases are estimated to be diagnosed within the U.S. The organization also reports about 442.4 cases of cancer per 100,000 individuals annually. Diabetes is another leading illness that affected 34.2 million people from different age groups that corresponds to 10.5% of the U.S. population.

Chronic allergy, asthma, anxiety, cardiovascular diseases, and neuropathy are among the prime illnesses that affect major chunks of the global population. Thus, due to such high prevalence, there has been a surge in demand for biologic and biosimilar drugs. The key pharmaceutical players across the globe have scaled up the production volumes to keep up with the market demands. Further, the emergence of new startups that are working on biosimilars accelerates market growth.

Global Bioreactors Market: Segmentation

Flexibility in Usage for Different Molecule Production and Cost-Efficiency of Reusable Bioreactors to Drive the Segment Growth

The reusable bioreactors segment dominates the market on account of its advantages, such as flexibility in usage for different molecule production, cost-efficiency, and increased yield has promoted substantial growth. Moreover, technological advancements are projected to drive the adoption rate of reusable bioreactors in the coming years. The single-use bioreactor segment, on the other hand, is expected to grow with the highest CAGR as it helps in reducing the need for cleaning, promotes higher sterilization, and reduces the risk of cross-contamination.

Vaccine Segment Holds the Largest Market Share in Terms of Revenue Generation

The vaccine segment holds the largest market share in terms of revenue generation, owing to the ever-growing demand for therapeutics for chronic diseases. As the prevalence of infectious diseases increases, the demand for vaccines is projected to exhibit significant growth in the bioreactors market. For instance, since its origin in December 2019, the coronavirus outbreak has caused havoc in the global healthcare network. The market demand for vaccines addressing the same has been sky-high, further boosting the vaccine development processes that build direct usage for bioreactors. Moreover, rising healthcare expenditure by the government to support research and drug discovery drives the market growth.

Regional Overview

North-America-Lead-Bioreactors-Market

The Presence of Key Market Players Largely Drives North America's, Bioreactors Market

North America's bioreactors market is largely driven by the presence of key market players that are constantly investing in research and development activities concerning drugs and vaccines. Also, governments across the region are actively supporting biologics production and providing funds for the same. The rising prevalence of chronic and infectious diseases in the region has surged the demand for therapeutics and bioreactors.   

Government Efforts to Boost the Production of Bioreactors Drives Asia-Pacific's Market Growth

Asia-Pacific's bioreactors market is witnessing significant growth on account of the surging expenditure of the biopharmaceutical startups and the governments in the field of bioreactors. For instance, umpteen research and startup grants are offered by the Indian Department of Science as well as the Department of Biotechnology, such as BIG grant and NIDHI Prayas Grant. Additionally, the region witnesses heavy investments from global leaders, such as Merck, Thermo Fischer, Agilent, and Eppendorf, due to favorable policies and availability of cheap labor in emerging economies, such as India and China.

Key Players

  • Sartorius Stedim Biotech (Germany)
  • Thermo Fisher Scientific, Inc. (the U.S.)
  • Merck KGaA (Germany)
  • GE Healthcare (the U.S.)
  • Danaher Corporation (the U.S.)
  • Eppendorf AG (Germany)
  • PBS Biotech
  • Cellexus Ltd.
  • Applikon Biotechnology, Inc.
  • BioTron, Inc.
  • Shanghai Bailun Biotechnology Co., Ltd.
  • CerCell
  • Solaris Biotech Solutions

Recent Developments

  • In September 2019, ABEC, the U.S. based biopharmaceutical manufacturing service provider, launched a customizable single-use bioreactor that can operate in a working volume of up to 6000L
  • In July 2019, Sartorius Stedim Biotech (SSB), a leading biopharmaceutical fermenter manufacturer, launched a new culture vessel for its product ambr 250 modular benchtop mini bioreactor with automated systems. The vessel is single-use and designed for therapeutic cell lines, which offers the potential for accelerated process development of cell and gene therapy applications

Bioreactors Market: Segmentation

By Product Type

  • Single-Use
  • Reusable

By Cell Type

  • Mammalian Cells
  • Bacterial Cells
  • Yeast Cells

By Molecule

  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Proteins
  • Stem Cells

By Reactor Volume

  • 5–20L
  • 20–250L
  • 250–1500L
  • Above 1500L

By End-User

  • Contract Research Organizations
  • Biopharmaceutical Companies
  • Research Labs
  • CMOS

By Region

  • Americas
  • Europe
  • Asia-Pacific
  • The Middle East and Africa

Frequently Asked Questions (FAQs)

The bioreactors market was valued at USD 4200 million in 2019 and is expected to grow with a CAGR of 16.5% during the forecast period.
Rising Incidence of Chronic Disorders, rising prevalence of chronic and infectious diseases are the key factors expected to drive Bioreactors Market during the forecast period.
North America is expected to hold the highest market share in Bioreactors Market.
Sartorius Stedim Biotech, Merck KGaA, GE Healthcare, Danaher Corporation, Eppendorf AG, PBS Biotech, Cellexus Ltd., Applikon Biotechnology, Inc., BioTron, Inc., Shanghai Bailun Biotechnology Co., Ltd., CerCell are the top players in Bioreactors Market.
In 2019 Global Bioreactors Market was valued at USD 4200 million.
Vaccine Segment is expected to be the leading segment in Bioreactors Market during the forecast period.
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available at all times and included in every purchase.
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
Basically, choose Pay by Purchase Order when you are checking out. We will connect with you via email to set up your order.

Bioreactors are specially designed containers that are used to grow organisms under user-controlled environments. Bioreactors provide support in the growth of cells (mammalian, bacterial, yeast) with an active environment and features that help in controlling, regulating, and monitoring the culture environment.

The bioreactors market was valued at USD 4200 million in 2019 and is expected to grow with a CAGR of 16.5% during the forecast period.

Bioreactors-Market

The COVID-19 Outbreak to Surge the Need for Rapid globally Vaccine Development

The demand for bioreactors in the global scenario has escalated significantly, owing to the chaos caused by the pandemic and the ever-growing demand for the development of vaccines and therapeutics. The pandemic has caused havoc and pressurized even the medical infrastructures into crisis. For instance, according to the World Health Organization (WHO), as of November 1, 2020, 45.9 million cases of COVID patients have been confirmed, with the death toll standing at 1.1 million globally.

Umpteen market players are collaborating for the development of effective vaccines to control the rising prevalence of the disease. Thus, demand from the bioreactors market has seen an upsurge in order to cater to the increasing need for fermentation and cell culture and support vaccine development. Further, government authorities and organizations in various regions are also taking up numerous initiatives and indulging in collaborations with key market players for proper management of vaccine development.

Bioreactors-Market-Growth

Rising Incidence of Chronic Disorders to Promote the Use of Bioreactors 

The world has been burdened with the growing incidence of chronic diseases that are affecting millions of people. As per the National Cancer Institute, in 2020, approximately 1.8 million cancer cases are estimated to be diagnosed within the U.S. The organization also reports about 442.4 cases of cancer per 100,000 individuals annually. Diabetes is another leading illness that affected 34.2 million people from different age groups that corresponds to 10.5% of the U.S. population.

Chronic allergy, asthma, anxiety, cardiovascular diseases, and neuropathy are among the prime illnesses that affect major chunks of the global population. Thus, due to such high prevalence, there has been a surge in demand for biologic and biosimilar drugs. The key pharmaceutical players across the globe have scaled up the production volumes to keep up with the market demands. Further, the emergence of new startups that are working on biosimilars accelerates market growth.

Global Bioreactors Market: Segmentation

Flexibility in Usage for Different Molecule Production and Cost-Efficiency of Reusable Bioreactors to Drive the Segment Growth

The reusable bioreactors segment dominates the market on account of its advantages, such as flexibility in usage for different molecule production, cost-efficiency, and increased yield has promoted substantial growth. Moreover, technological advancements are projected to drive the adoption rate of reusable bioreactors in the coming years. The single-use bioreactor segment, on the other hand, is expected to grow with the highest CAGR as it helps in reducing the need for cleaning, promotes higher sterilization, and reduces the risk of cross-contamination.

Vaccine Segment Holds the Largest Market Share in Terms of Revenue Generation

The vaccine segment holds the largest market share in terms of revenue generation, owing to the ever-growing demand for therapeutics for chronic diseases. As the prevalence of infectious diseases increases, the demand for vaccines is projected to exhibit significant growth in the bioreactors market. For instance, since its origin in December 2019, the coronavirus outbreak has caused havoc in the global healthcare network. The market demand for vaccines addressing the same has been sky-high, further boosting the vaccine development processes that build direct usage for bioreactors. Moreover, rising healthcare expenditure by the government to support research and drug discovery drives the market growth.

Regional Overview

North-America-Lead-Bioreactors-Market

The Presence of Key Market Players Largely Drives North America's, Bioreactors Market

North America's bioreactors market is largely driven by the presence of key market players that are constantly investing in research and development activities concerning drugs and vaccines. Also, governments across the region are actively supporting biologics production and providing funds for the same. The rising prevalence of chronic and infectious diseases in the region has surged the demand for therapeutics and bioreactors.   

Government Efforts to Boost the Production of Bioreactors Drives Asia-Pacific's Market Growth

Asia-Pacific's bioreactors market is witnessing significant growth on account of the surging expenditure of the biopharmaceutical startups and the governments in the field of bioreactors. For instance, umpteen research and startup grants are offered by the Indian Department of Science as well as the Department of Biotechnology, such as BIG grant and NIDHI Prayas Grant. Additionally, the region witnesses heavy investments from global leaders, such as Merck, Thermo Fischer, Agilent, and Eppendorf, due to favorable policies and availability of cheap labor in emerging economies, such as India and China.

Key Players

  • Sartorius Stedim Biotech (Germany)
  • Thermo Fisher Scientific, Inc. (the U.S.)
  • Merck KGaA (Germany)
  • GE Healthcare (the U.S.)
  • Danaher Corporation (the U.S.)
  • Eppendorf AG (Germany)
  • PBS Biotech
  • Cellexus Ltd.
  • Applikon Biotechnology, Inc.
  • BioTron, Inc.
  • Shanghai Bailun Biotechnology Co., Ltd.
  • CerCell
  • Solaris Biotech Solutions

Recent Developments

  • In September 2019, ABEC, the U.S. based biopharmaceutical manufacturing service provider, launched a customizable single-use bioreactor that can operate in a working volume of up to 6000L
  • In July 2019, Sartorius Stedim Biotech (SSB), a leading biopharmaceutical fermenter manufacturer, launched a new culture vessel for its product ambr 250 modular benchtop mini bioreactor with automated systems. The vessel is single-use and designed for therapeutic cell lines, which offers the potential for accelerated process development of cell and gene therapy applications

Bioreactors Market: Segmentation

By Product Type

  • Single-Use
  • Reusable

By Cell Type

  • Mammalian Cells
  • Bacterial Cells
  • Yeast Cells

By Molecule

  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Proteins
  • Stem Cells

By Reactor Volume

  • 5–20L
  • 20–250L
  • 250–1500L
  • Above 1500L

By End-User

  • Contract Research Organizations
  • Biopharmaceutical Companies
  • Research Labs
  • CMOS

By Region

  • Americas
  • Europe
  • Asia-Pacific
  • The Middle East and Africa

Frequently Asked Questions (FAQs)

The bioreactors market was valued at USD 4200 million in 2019 and is expected to grow with a CAGR of 16.5% during the forecast period.
Rising Incidence of Chronic Disorders, rising prevalence of chronic and infectious diseases are the key factors expected to drive Bioreactors Market during the forecast period.
North America is expected to hold the highest market share in Bioreactors Market.
Sartorius Stedim Biotech, Merck KGaA, GE Healthcare, Danaher Corporation, Eppendorf AG, PBS Biotech, Cellexus Ltd., Applikon Biotechnology, Inc., BioTron, Inc., Shanghai Bailun Biotechnology Co., Ltd., CerCell are the top players in Bioreactors Market.
In 2019 Global Bioreactors Market was valued at USD 4200 million.
Vaccine Segment is expected to be the leading segment in Bioreactors Market during the forecast period.
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available at all times and included in every purchase.
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
Basically, choose Pay by Purchase Order when you are checking out. We will connect with you via email to set up your order.